Evaluation of G2013 (&#945;-L-guluronic acid) efficacy on PC-3 cells through inhibiting the expression of inflammatory factors.

Bagherian, Zahra; Mirshafiey, Abbas; Mohsenzadegan, Monireh; Farajollahi, Mohammad M

Evaluation of G2013 (α-L-guluronic acid) efficacy on PC-3 cells through inhibiting the expression of inflammatory factors.

Bagherian, Zahra; Mirshafiey, Abbas; Mohsenzadegan, Monireh; Farajollahi, Mohammad M.

Afiliación

Bagherian Z; Department of Medical Biotechnology, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.
Mirshafiey A; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mohsenzadegan M; Department of Medical Laboratory Science, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.
Farajollahi MM; Department of Medical Biotechnology, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.

Clin Exp Pharmacol Physiol ; 49(2): 254-263, 2022 02.

Article en En | MEDLINE | ID: mdl-34699087

Asunto(s)

Metaloproteinasa 2 de la Matriz; FN-kappa B; Ácidos Hexurónicos/farmacología; Humanos; Masculino; Metaloproteinasa 2 de la Matriz/genética; FN-kappa B/metabolismo; Células PC-3

Palabras clave

G2013; guluronic acid; immunomodulation; inflammatory mediators; non-steroidal anti-inflammatory drugs; prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: FN-kappa B / Metaloproteinasa 2 de la Matriz Idioma: En Revista: Clin Exp Pharmacol Physiol Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google